Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/23611Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Korantzopoulos, P. | en |
| dc.contributor.author | Kokkoris, S. | en |
| dc.contributor.author | Liu, T. | en |
| dc.contributor.author | Protopsaltis, I. | en |
| dc.contributor.author | Li, G. | en |
| dc.contributor.author | Goudevenos, J. A. | en |
| dc.date.accessioned | 2015-11-24T19:34:14Z | - |
| dc.date.available | 2015-11-24T19:34:14Z | - |
| dc.identifier.issn | 0147-8389 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/23611 | - |
| dc.rights | Default Licence | - |
| dc.subject | *Atrial Fibrillation/diagnosis/mortality/therapy | en |
| dc.subject | Comorbidity | en |
| dc.subject | Humans | en |
| dc.subject | *Kidney Failure, Chronic/diagnosis/mortality/therapy | en |
| dc.title | Atrial fibrillation in end-stage renal disease | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.1111/j.1540-8159.2007.00877.x | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/17976105 | - |
| heal.identifier.secondary | http://onlinelibrary.wiley.com/store/10.1111/j.1540-8159.2007.00877.x/asset/j.1540-8159.2007.00877.x.pdf?v=1&t=h0tb7hr1&s=ce766bcb6dc79d2bc7b54e17450a6cec25bd86e1 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2007 | - |
| heal.abstract | End-stage renal disease (ESRD) is associated with increased cardiovascular morbidity and mortality. Recent studies indicate that atrial fibrillation (AF) is prevalent among ESRD patients while it adversely affects the clinical outcome. Despite these considerations, AF management in this population is problematic. Notably, most ESRD patients with AF are deprived of the benefits of anticoagulation therapy because of the fear of hemorrhagic complications. This article provides a concise and critical overview of the complex pathophysiology, epidemiology, and discusses the clinical issues regarding the emerging association between ESRD and AF. | en |
| heal.journalName | Pacing Clin Electrophysiol | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Korantzopoulos-2007-Atrial fibrillation.pdf | 95.96 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
